Stay updated with breaking news from Hal Barron. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LONDON, Dec 7 — British drugmaker GSK said today its antibody-based Covid-19 therapy with US partner Vir Biotechnology is effective against all mutations of the new Omicron coronavirus variant, citing new data from early-stage studies. The data, yet to be published in a peer-reviewed medical...
– New preclinical findings generated through in vitro testing of sotrovimab againstthe complete pseudo-virus updated to bioRxiv – Data build on promising signal published... | December 7, 2021
The data, yet to be published in a peer-reviewed medical journal, shows the treatment, sotrovimab, is effective against all 37 identified mutations to date in the spike protein, GSK says
07.12.2021 - – New preclinical findings generated through in vitro testing of sotrovimab againstthe complete pseudo-virus updated to bioRxiv – Data build on promising signal published last week, underscoring the importance of sotrovimab for early treatment of ...
British drugmaker GSK said on Tuesday its antibody based COVID 19 therapy with U.S. partner Vir Biotechnology is effective against all mutations of th...